West Pharmaceutical Services Inc
WST· NYSE
Released Oct 24, 2024, before the open
10-Q filed Oct 24, 2024, 24 days after period end · 0000105770-24-000081
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $746.90M | $747.40M | $686.90M | $706.50M |
| Net Income | $136.00M | $161.30M | $120.60M | $175.60M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $1.85 |
| $2.14 |
| $1.59 |
| $2.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.